BRISTOL-MYERS SQUIBB COMPANY Severance Costs
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Severance Costs of $48.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY severance costs for the quarter ending 2026-06-30 was $48.00M, a 78.18% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY severance costs for the quarter ending 2026-03-31 was -$2.00M, a 101.52% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY severance costs for the quarter ending 2025-12-31 was $125.00M, a 81.16% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY severance costs for the quarter ending 2025-09-30 was $71.00M, a 7.79% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY severance costs for fiscal 2025 was $548.00M, a 12.04% decline from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY severance costs for fiscal 2024 was $623.00M, a 78.00% increase from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY severance costs for fiscal 2023 was $350.00M, a 407.25% increase from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY severance costs for fiscal 2022 was $69.00M, a 56.60% decline from fiscal 2021.
| Period end | Severance Costs 3 month | Severance Costs 6 month | Severance Costs 9 month | Severance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $48.00M 10-Q · filed 2026-07-30 | $46.00M 10-Q · filed 2026-07-30 | $171.00M derived: sum of 3 quarters · filed 2026-07-30 | $242.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$2.00M 10-Q · filed 2026-04-30 | $123.00M derived: sum of 2 quarters · filed 2026-04-30 | $194.00M derived: sum of 3 quarters · filed 2026-04-30 | $414.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $125.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $196.00M derived: sum of 2 quarters · filed 2026-02-11 | $416.00M derived: sum of 3 quarters · filed 2026-07-30 | $548.00M 10-K · filed 2026-02-11 |
| 2025-09-30 | $71.00M 10-Q · filed 2025-10-30 | $291.00M derived: sum of 2 quarters · filed 2026-07-30 | $423.00M 10-Q · filed 2025-10-30 | $492.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $220.00M 10-Q · filed 2026-07-30 | $352.00M 10-Q · filed 2026-07-30 | $421.00M derived: sum of 3 quarters · filed 2026-07-30 | $498.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $132.00M 10-Q · filed 2026-04-30 | $201.00M derived: sum of 2 quarters · filed 2026-04-30 | $278.00M derived: sum of 3 quarters · filed 2026-04-30 | $538.00M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $69.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $146.00M derived: sum of 2 quarters · filed 2026-02-11 | $406.00M derived: sum of 3 quarters · filed 2026-02-11 | $623.00M 10-K · filed 2026-02-11 |
| 2024-09-30 | $77.00M 10-Q · filed 2025-10-30 | $337.00M derived: sum of 2 quarters · filed 2025-10-30 | $554.00M 10-Q · filed 2025-10-30 | $595.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $260.00M 10-Q · filed 2025-07-31 | $477.00M 10-Q · filed 2025-07-31 | $518.00M derived: sum of 3 quarters · filed 2026-02-11 | $653.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $217.00M 10-Q · filed 2025-04-24 | $258.00M derived: sum of 2 quarters · filed 2026-02-11 | $393.00M derived: sum of 3 quarters · filed 2026-02-11 | $502.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $41.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $176.00M derived: sum of 2 quarters · filed 2026-02-11 | $285.00M derived: sum of 3 quarters · filed 2026-02-11 | $350.00M 10-K · filed 2026-02-11 |
| 2023-09-30 | $135.00M 10-Q · filed 2024-10-31 | $244.00M derived: sum of 2 quarters · filed 2024-10-31 | $309.00M 10-Q · filed 2024-10-31 | $321.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $109.00M 10-Q · filed 2024-07-26 | $174.00M 10-Q · filed 2024-07-26 | $186.00M derived: sum of 3 quarters · filed 2025-02-12 | $202.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $65.00M 10-Q · filed 2024-04-25 | $77.00M derived: sum of 2 quarters · filed 2025-02-12 | $93.00M derived: sum of 3 quarters · filed 2025-02-12 | $112.00M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $28.00M derived: sum of 2 quarters · filed 2025-02-12 | $47.00M derived: sum of 3 quarters · filed 2025-02-12 | $69.00M 10-K · filed 2025-02-12 |
| 2022-09-30 | $16.00M 10-Q · filed 2023-10-26 | $35.00M derived: sum of 2 quarters · filed 2023-10-26 | $57.00M 10-Q · filed 2023-10-26 | $73.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $19.00M 10-Q · filed 2023-07-27 | $41.00M 10-Q · filed 2023-07-27 | $57.00M derived: sum of 3 quarters · filed 2024-02-13 | $81.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $22.00M 10-Q · filed 2023-04-27 | $38.00M derived: sum of 2 quarters · filed 2024-02-13 | $62.00M derived: sum of 3 quarters · filed 2024-02-13 | $137.00M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $40.00M derived: sum of 2 quarters · filed 2024-02-13 | $115.00M derived: sum of 3 quarters · filed 2024-02-13 | $159.00M 10-K · filed 2024-02-13 |
| 2021-09-30 | $24.00M 10-Q · filed 2022-10-26 | $99.00M derived: sum of 2 quarters · filed 2022-10-26 | $143.00M 10-Q · filed 2022-10-26 | $211.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $75.00M 10-Q · filed 2022-07-27 | $119.00M 10-Q · filed 2022-07-27 | $187.00M derived: sum of 3 quarters · filed 2023-02-14 | $320.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $44.00M 10-Q · filed 2022-04-29 | $112.00M derived: sum of 2 quarters · filed 2023-02-14 | $245.00M derived: sum of 3 quarters · filed 2023-02-14 | $352.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $201.00M derived: sum of 2 quarters · filed 2023-02-14 | $308.00M derived: sum of 3 quarters · filed 2023-02-14 | $457.00M 10-K · filed 2023-02-14 |
| 2020-09-30 | $133.00M 10-Q · filed 2021-10-27 | $240.00M derived: sum of 2 quarters · filed 2021-10-27 | $389.00M 10-Q · filed 2021-10-27 | $651.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-06-30 | $107.00M 10-Q · filed 2021-07-28 | $256.00M 10-Q · filed 2021-07-28 | $518.00M derived: sum of 3 quarters · filed 2022-02-09 | $522.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-03-31 | $149.00M 10-Q · filed 2021-04-29 | $411.00M derived: sum of 2 quarters · filed 2022-02-09 | $415.00M derived: sum of 3 quarters · filed 2022-02-09 | $418.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2019-12-31 | $262.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $266.00M derived: sum of 2 quarters · filed 2022-02-09 | $269.00M derived: sum of 3 quarters · filed 2022-02-09 | $273.00M 10-K · filed 2022-02-09 |
| 2019-09-30 | $4.00M 10-Q · filed 2019-10-31 | $7.00M derived: sum of 2 quarters · filed 2019-10-31 | $11.00M 10-Q · filed 2019-10-31 | $26.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-06-30 | $3.00M 10-Q · filed 2019-07-25 | $7.00M 10-Q · filed 2019-07-25 | $22.00M derived: sum of 3 quarters · filed 2021-02-10 | $59.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-03-31 | $4.00M 10-Q · filed 2019-04-25 | $19.00M derived: sum of 2 quarters · filed 2021-02-10 | $56.00M derived: sum of 3 quarters · filed 2021-02-10 | $82.00M derived: sum of 4 quarters · filed 2021-02-10 |
| 2018-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $52.00M derived: sum of 2 quarters · filed 2021-02-10 | $78.00M derived: sum of 3 quarters · filed 2021-02-10 | $87.00M 10-K · filed 2021-02-10 |
| 2018-09-30 | $37.00M 10-Q · filed 2019-10-31 | $63.00M derived: sum of 2 quarters · filed 2019-10-31 | $72.00M 10-Q · filed 2019-10-31 | $149.00M derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-06-30 | $26.00M 10-Q · filed 2019-07-25 | $35.00M 10-Q · filed 2019-07-25 | $112.00M derived: sum of 3 quarters · filed 2019-07-25 | $130.00M derived: sum of 4 quarters · filed 2019-07-25 |
| 2018-03-31 | $9.00M 10-Q · filed 2019-04-25 | $86.00M derived: sum of 2 quarters · filed 2019-04-25 | $104.00M derived: sum of 3 quarters · filed 2019-04-25 | $115.00M derived: sum of 4 quarters · filed 2019-04-25 |
| 2017-12-31 | $77.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $95.00M derived: sum of 2 quarters · filed 2019-02-25 | $106.00M derived: sum of 3 quarters · filed 2019-02-25 | $267.00M 10-K · filed 2019-02-25 |
| 2017-09-30 | $18.00M 10-Q · filed 2017-10-26 | $29.00M derived: sum of 2 quarters · filed 2017-10-26 | $190.00M 10-Q · filed 2017-10-26 | $255.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $11.00M 10-Q · filed 2017-07-27 | $172.00M 10-Q · filed 2017-07-27 | $237.00M derived: sum of 3 quarters · filed 2019-02-25 | $254.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $161.00M 10-Q · filed 2017-04-27 | $226.00M derived: sum of 2 quarters · filed 2019-02-25 | $243.00M derived: sum of 3 quarters · filed 2019-02-25 | $254.00M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $65.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $82.00M derived: sum of 2 quarters · filed 2019-02-25 | $93.00M derived: sum of 3 quarters · filed 2019-02-25 | $97.00M 10-K · filed 2019-02-25 |
| 2016-09-30 | $17.00M 10-Q · filed 2017-10-26 | $28.00M derived: sum of 2 quarters · filed 2017-10-26 | $32.00M 10-Q · filed 2017-10-26 | $97.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $11.00M 10-Q · filed 2017-07-27 | $15.00M 10-Q · filed 2017-07-27 | $80.00M derived: sum of 3 quarters · filed 2018-02-13 | $89.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $4.00M 10-Q · filed 2017-04-27 | $69.00M derived: sum of 2 quarters · filed 2018-02-13 | $78.00M derived: sum of 3 quarters · filed 2018-02-13 | $104.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $65.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $74.00M derived: sum of 2 quarters · filed 2018-02-13 | $100.00M derived: sum of 3 quarters · filed 2018-02-13 | $110.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | $9.00M 10-Q · filed 2015-10-27 | $35.00M derived: sum of 2 quarters · filed 2015-10-27 | $45.00M 10-Q · filed 2015-10-27 | $134.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-06-30 | $26.00M 10-Q · filed 2015-07-23 | $36.00M 10-Q · filed 2015-07-23 | $125.00M derived: sum of 3 quarters · filed 2017-02-21 | $159.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2015-03-31 | $10.00M 10-Q · filed 2015-04-28 | $99.00M derived: sum of 2 quarters · filed 2017-02-21 | $133.00M derived: sum of 3 quarters · filed 2017-02-21 | $147.00M derived: sum of 4 quarters · filed 2017-02-21 |
| 2014-12-31 | $89.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $123.00M derived: sum of 2 quarters · filed 2017-02-21 | $137.00M derived: sum of 3 quarters · filed 2017-02-21 | $157.00M 10-K · filed 2017-02-21 |
| 2014-09-30 | $34.00M 10-Q · filed 2015-10-27 | $48.00M derived: sum of 2 quarters · filed 2015-10-27 | $68.00M 10-Q · filed 2015-10-27 | $74.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $14.00M 10-Q · filed 2015-07-23 | $34.00M 10-Q · filed 2015-07-23 | $40.00M derived: sum of 3 quarters · filed 2016-02-12 | $44.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $20.00M 10-Q · filed 2015-04-28 | $26.00M derived: sum of 2 quarters · filed 2016-02-12 | $30.00M derived: sum of 3 quarters · filed 2016-02-12 | $202.00M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $10.00M derived: sum of 2 quarters · filed 2016-02-12 | $182.00M derived: sum of 3 quarters · filed 2016-02-12 | $211.00M 10-K · filed 2016-02-12 |
| 2013-09-30 | $4.00M 10-Q · filed 2014-10-24 | $176.00M derived: sum of 2 quarters · filed 2014-10-24 | $205.00M 10-Q · filed 2014-10-24 | $294.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | $172.00M 10-Q · filed 2014-07-24 | $201.00M 10-Q · filed 2014-07-24 | $290.00M derived: sum of 3 quarters · filed 2015-02-13 | $311.00M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | $29.00M 10-Q · filed 2014-04-29 | $118.00M derived: sum of 2 quarters · filed 2015-02-13 | $139.00M derived: sum of 3 quarters · filed 2015-02-13 | |
| 2012-12-31 | $89.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $110.00M derived: sum of 2 quarters · filed 2015-02-13 | $145.00M 10-K · filed 2015-02-13 | |
| 2012-09-30 | $21.00M 10-Q · filed 2013-10-23 | $56.00M 10-Q · filed 2013-10-23 | ||
| 2011-12-31 | $85.00M 10-K · filed 2014-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |